Effect of Sukshma Vyayama Yoga on Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors
Completed · Not applicable
Conditions studied: Breast Cancer
In brief
The purpose of this study is to investigate the efficacy of sukshma vyayama joint loosening yoga in improving aromatase inhibitor-induced arthralgia in post-menopausal breast cancer survivors and secondarily, to evaluate the feasibility of delivering the intervention on Facebook.
Key facts
- Study ID
- NCT04042870
- Run by
- AshtaYoga, LLC
- People needed
- 38
- Starts
- 2018-09-04
- Expected to finish
- 2018-10-19
- Last updated by the study team
- 2019-08-02
Who can join
Age: 35 and older, up to 70. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Postmenopausal breast cancer survivors undergoing treatment with aromatase inhibitor hormonal therapy with self-reported arthralgia
- Must have initiated anastrazole, exemestane, or letrozole within 30 days of baseline assessment
- 35-70 years old
- Must be available during the dates of the study and willing to participate in the study
- Must have access to computer, tablet or smart phone and Internet connection
- Must be a member of Facebook
- Eligible if their arthralgia started after initiation of an AI or if they had preexisting joint pain that was exacerbated by AI use
- English speaking
You may not qualify if…
- Non English-speaking
- Physically unable to perform the intervention
Where it is running
- Columbia University Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.